Amundi Has $13.80 Million Stock Holdings in Merit Medical Systems, Inc. $MMSI

Amundi lifted its holdings in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) by 2.2% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 132,780 shares of the medical instruments supplier’s stock after purchasing an additional 2,847 shares during the quarter. Amundi owned approximately 0.22% of Merit Medical Systems worth $13,804,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of the business. Opal Wealth Advisors LLC bought a new stake in Merit Medical Systems in the first quarter worth $31,000. IFP Advisors Inc boosted its stake in shares of Merit Medical Systems by 1,435.0% during the 1st quarter. IFP Advisors Inc now owns 307 shares of the medical instruments supplier’s stock worth $32,000 after acquiring an additional 287 shares in the last quarter. Northwestern Mutual Wealth Management Co. boosted its stake in shares of Merit Medical Systems by 119.8% during the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 367 shares of the medical instruments supplier’s stock worth $39,000 after acquiring an additional 200 shares in the last quarter. Bayforest Capital Ltd acquired a new position in shares of Merit Medical Systems during the 1st quarter valued at about $41,000. Finally, Versant Capital Management Inc raised its stake in shares of Merit Medical Systems by 1,518.5% in the 1st quarter. Versant Capital Management Inc now owns 437 shares of the medical instruments supplier’s stock valued at $46,000 after acquiring an additional 410 shares in the last quarter. Institutional investors own 99.66% of the company’s stock.

Wall Street Analyst Weigh In

MMSI has been the topic of several analyst reports. Barrington Research reiterated an “outperform” rating and set a $103.00 price target on shares of Merit Medical Systems in a report on Thursday, July 31st. Piper Sandler dropped their target price on shares of Merit Medical Systems from $110.00 to $105.00 and set an “overweight” rating on the stock in a report on Thursday, July 31st. Wells Fargo & Company decreased their price target on shares of Merit Medical Systems from $108.00 to $100.00 and set an “overweight” rating for the company in a report on Thursday, July 31st. Canaccord Genuity Group set a $112.00 price target on Merit Medical Systems and gave the company a “buy” rating in a research report on Wednesday, May 21st. Finally, Needham & Company LLC reiterated a “buy” rating and issued a $108.00 price objective on shares of Merit Medical Systems in a research note on Friday, July 18th. Eight research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $107.00.

Insider Buying and Selling

In other Merit Medical Systems news, Director Lynne N. Ward sold 3,000 shares of the business’s stock in a transaction on Friday, August 22nd. The shares were sold at an average price of $88.56, for a total value of $265,680.00. Following the sale, the director owned 12,809 shares of the company’s stock, valued at $1,134,365.04. The trade was a 18.98% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CFO Raul Jr. Parra sold 15,181 shares of the stock in a transaction on Friday, June 13th. The shares were sold at an average price of $93.75, for a total transaction of $1,423,218.75. Following the completion of the transaction, the chief financial officer owned 24,201 shares of the company’s stock, valued at approximately $2,268,843.75. This represents a 38.55% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 20,614 shares of company stock worth $1,895,436. 3.70% of the stock is currently owned by company insiders.

Merit Medical Systems Stock Performance

NASDAQ:MMSI opened at $91.66 on Wednesday. The firm’s 50-day moving average is $88.18 and its 200-day moving average is $93.61. The company has a market cap of $5.43 billion, a price-to-earnings ratio of 46.53, a PEG ratio of 2.99 and a beta of 0.64. The company has a debt-to-equity ratio of 0.49, a quick ratio of 2.66 and a current ratio of 4.09. Merit Medical Systems, Inc. has a 52-week low of $81.04 and a 52-week high of $111.45.

Merit Medical Systems (NASDAQ:MMSI) last released its earnings results on Wednesday, July 30th. The medical instruments supplier reported $1.01 earnings per share for the quarter, topping analysts’ consensus estimates of $0.85 by $0.16. The business had revenue of $382.46 million for the quarter, compared to the consensus estimate of $372.47 million. Merit Medical Systems had a return on equity of 15.07% and a net margin of 8.31%.The firm’s revenue for the quarter was up 13.2% compared to the same quarter last year. During the same period last year, the business earned $0.92 earnings per share. Equities research analysts anticipate that Merit Medical Systems, Inc. will post 3.37 earnings per share for the current year.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.